Related Experiment Video
Updated: Jun 5, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Oxidative stress in patients with COPD.
Stelios Loukides1, Petros Bakakos, Konstantinos Kostikas
11st and 2nd Respiratory Department, University of Athens Medical School, Athens, Greece. ssat@hol.gr
The lungs face oxidative stress from air pollution, impacting Chronic Obstructive Pulmonary Disease (COPD). Antioxidant therapies are needed but require precise definition for effective COPD management.
Area of Science:
- Pulmonary Medicine
- Oxidative Stress Research
- Biomarker Discovery
Background:
- The lungs are highly susceptible to oxidative injury due to high ambient air exposure and abundant blood supply.
- Reactive oxygen species (ROS) and free radicals cause oxidative stress, which is implicated in Chronic Obstructive Pulmonary Disease (COPD) pathogenesis.
- An imbalance between oxidants and antioxidants is evident in smokers and COPD patients, influencing proinflammatory gene expression.
Purpose of the Study:
- To explore the role of oxidative stress in COPD.
- To review the challenges in detecting and evaluating oxidative burden using biomarkers.
- To discuss the need for effective antioxidant therapy in COPD management.
Main Methods:
- Review of existing literature on oxidative stress and COPD.
- Analysis of invasive and non-invasive biomarkers for oxidative stress in airways.
- Evaluation of current and potential antioxidant therapies for COPD.
Main Results:
- Oxidative stress significantly influences molecular mechanisms driving inflammation in COPD.
- Biomarker detection for oxidative burden in COPD remains challenging.
- Several antioxidant agents show potential but clinical trials have not yet defined optimal treatment strategies.
Conclusions:
- Effective, bioavailable, wide-spectrum antioxidant therapy is crucial for managing COPD's local and systemic oxidative stress.
- Further research is needed to determine the optimal type, regimen, and duration of antioxidant treatment for clinically meaningful outcomes in COPD patients.
More Related Videos
09:33Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors
Published on: February 7, 2018
04:03Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
Published on: September 27, 2024
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Management Using Bronchodilators and Corticosteroids